We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

87 hedge funds and large institutions have $190M invested in Foghorn Therapeutics in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

10% more funds holding

Funds holding: 79 → 87 (+8)

0.12% more ownership

Funds ownership: 72.29% → 72.41% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

49% less capital invested

Capital invested by funds: $372M → $190M (-$182M)

Holders
87
Holders Change
+8
Holders Change %
+10.13%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
32
Reduced
12
Closed
8
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$66K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.71M
2
DM
Deerfield Management
New York
+$1.66M
3
BlackRock
BlackRock
New York
+$1.59M
4
DCM
DAFNA Capital Management
California
+$1.09M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$688K

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.69M
2
Citadel Advisors
Citadel Advisors
Florida
-$756K
3
BCM
Bridgeway Capital Management
Texas
-$182K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$173K
5
Jane Street
Jane Street
New York
-$173K
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Trexquant Investment
Connecticut
$291K +$7.24K +994 +2%
N
27
Nuveen
North Carolina
$285K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$275K +$14.3K +1,965 +3%
JP Morgan Chase
29
JP Morgan Chase
New York
$267K +$332K +45,565 +416%
PAM
30
Panagora Asset Management
Massachusetts
$260K +$116K +15,913 +41%
Barclays
31
Barclays
United Kingdom
$244K +$85.2K +11,689 +29%
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$234K +$212K +29,094 +142%
Renaissance Technologies
33
Renaissance Technologies
New York
$225K +$164K +22,500 +89%
BBA
34
Baker Bros. Advisors
New York
$213K – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$194K +$176K +24,200 +143%
UBS Group
36
UBS Group
Switzerland
$177K +$186K +25,565 +214%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$172K +$22.2K +3,049 +9%
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$168K -$48K -6,583 -16%
CC
39
Corton Capital
Ontario, Canada
$163K -$135K -18,530 -35%
Walleye Capital
40
Walleye Capital
New York
$161K -$79.3K -10,879 -24%
BCM
41
Bridgeway Capital Management
Texas
$158K -$182K -25,000 -43%
Bank of America
42
Bank of America
North Carolina
$149K +$29.2K +4,002 +14%
WWA
43
Wingate Wealth Advisors
Massachusetts
$134K +$207K +28,471 New
Citigroup
44
Citigroup
New York
$94.5K +$12.3K +1,687 +9%
HSBC Holdings
45
HSBC Holdings
United Kingdom
$88.2K +$15K +2,061 +12%
ETC
46
Exchange Traded Concepts
Oklahoma
$85.4K – – –
AllianceBernstein
47
AllianceBernstein
Tennessee
$82K – – –
Los Angeles Capital Management
48
Los Angeles Capital Management
California
$74.8K +$115K +15,851 New
Wells Fargo
49
Wells Fargo
California
$74.8K +$28.8K +3,958 +33%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$74.6K -$173K -23,793 -60%
1
2
3 4

FHTX Hedge Fund Activity: Q4 2024 in Review

87 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2024, worth a combined $190M — down 49% from $372M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new FHTX positions and 8 closed out — a net gain of 9 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $1.71M. The largest seller was Fidelity Investments, cutting an estimated $4.69M.

  • 87 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2024, up from 79 in Q3 2024.
  • Funds reported $190M of Foghorn Therapeutics stock for Q4 2024, down 49% quarter-over-quarter.
  • 17 funds opened new Foghorn Therapeutics positions in Q4 2024 and 8 closed out, a net change of +9 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2024 was Point72 Asset Management, an estimated $1.71M added.
  • The largest Foghorn Therapeutics seller in Q4 2024 was Fidelity Investments, an estimated $4.69M sold.

Based on aggregated 13F filings for Q4 2024.